Developing a Successful Biopharmaceutical Pricing & Market Access Strategy

PM&A course 20 April - 8 June 2023

Registration is now open for “Developing a Successful Biopharmaceutical Pricing & Market Access Strategy”, our executive education programme, which is a collaboration between the Cambridge Academy of Therapeutic Sciences (CATS) at the University of Cambridge and Windrose Consulting Group.

All course information can be found on our P&MA course page, which can be found by clicking below:

 

About Windrose

Windrose Consulting Group helps life science companies maximize the commercial value of their products. We develop strategies and recommendations focused on product and portfolio planning, pricing and market access, and value communication.

About CATS

The Cambridge Academy of Therapeutic Sciences (CATS) is a Strategic Research Initiative of the University of Cambridge, established to facilitate the development of new therapeutics and support the education and training of the next generation of world-leading researchers.

Previous
Previous

Greg Certo, joins the Windrose office in Philadelphia

Next
Next

Colin Banks, Anant Sriram and Georgia Schonberg promoted